Literature DB >> 8788943

Synthesis and release of an acetylcholine-like compound by human myoblasts and myotubes.

M Hamann1, M C Chamoin, P Portalier, L Bernheim, A Baroffio, H Widmer, C R Bader, J P Ternaux.   

Abstract

1. Exogenously applied acetylcholine (ACh) is a modulator of human myoblast fusion. Using a chemiluminescent method, we examined whether an endogenous ACh-like compound (ACh-lc) was present in, and released by, pure human myogenic cells. 2. Single, freshly isolated satellite cells and proliferating myoblasts contained 15 and 0.5 fmol ACh-lc, respectively. Cultured myotubes contained ACh-lc as well. Also, ACh-like immunoreactivity was detected in all myogenic cells. 3. Part of the ACh-lc was synthesized by choline acetyltransferase (ChAT), as indicated by the reduction of ACh-lc content when bromoACh was present in the culture medium, and by direct measurements of ChAT activity. Also, ChAT-like immunoreactivity was observed in all myogenic cells. 4. Myoblasts and myotubes released ACh-lc spontaneously by a partially Ca(2+)-dependent mechanism. 5. The application by microperfusion of medium conditioned beforehand by myoblasts (thus presumably containing ACh-lc) onto a voltage-clamped myotube induced inward currents resembling ACh-induced currents in their kinetics, reversal potential, and sensitivity to nicotinic antagonists. 6. In vitro, the spontaneously released ACh-lc promoted myoblast fusion but only in the presence of an anticholinesterase. 7. Our observations indicate that human myogenic cells synthesize and release an ACh-lc and thereby promote the fusion process that occurs in muscle during growth or regeneration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788943      PMCID: PMC1156848          DOI: 10.1113/jphysiol.1995.sp021092

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  43 in total

1.  An analysis of acetylcholine in frog muscle by mass fragmentography.

Authors:  R Miledi; P C Molenaar; R L Polak
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-06-15

Review 2.  The present status of the vesicular hypothesis.

Authors:  M Israel; Y Dunant; R Manaranche
Journal:  Prog Neurobiol       Date:  1979       Impact factor: 11.685

3.  Immunocytochemical detection of acetylcholine in the rat central nervous system.

Authors:  M Geffard; A McRae-Degueurce; M L Souan
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

4.  Single acetylcholine-activated channel currents in developing muscle cells.

Authors:  S A Siegelbaum; A Trautmann; J Koenig
Journal:  Dev Biol       Date:  1984-08       Impact factor: 3.582

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Cholinergic transmission regulates extrajunctional acetylcholine receptors.

Authors:  A Pestronk; D B Drachman; E F Stanley; D L Price; J W Griffin
Journal:  Exp Neurol       Date:  1980-12       Impact factor: 5.330

Review 7.  The muscle satellite cell: a review.

Authors:  D R Campion
Journal:  Int Rev Cytol       Date:  1984

8.  Somatic Acetylcholine Release in Rabbit Nodose Ganglion.

Authors:  B. Palouzier-Paulignan; M.-C. Chamoin; J.-P. Ternaux
Journal:  Eur J Neurosci       Date:  1992-10       Impact factor: 3.386

9.  Interactive effects of serotonin and acetylcholine on neurite elongation.

Authors:  D P McCobb; C S Cohan; J A Connor; S B Kater
Journal:  Neuron       Date:  1988-07       Impact factor: 17.173

10.  Activation of nicotinic acetylcholine receptors increases the rate of fusion of cultured human myoblasts.

Authors:  R M Krause; M Hamann; C R Bader; J H Liu; A Baroffio; L Bernheim
Journal:  J Physiol       Date:  1995-12-15       Impact factor: 5.182

View more
  8 in total

1.  Soluble miniagrin enhances contractile function of engineered skeletal muscle.

Authors:  Weining Bian; Nenad Bursac
Journal:  FASEB J       Date:  2011-11-10       Impact factor: 5.191

2.  Role of an inward rectifier K+ current and of hyperpolarization in human myoblast fusion.

Authors:  J H Liu; P Bijlenga; J Fischer-Lougheed; T Occhiodoro; A Kaelin; C R Bader; L Bernheim
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

3.  Immunohistochemical evidence suggests intrinsic regulatory activity of human eccrine sweat glands.

Authors:  C Zancanaro; F Merigo; C Crescimanno; S Orlandini; A Osculati
Journal:  J Anat       Date:  1999-04       Impact factor: 2.610

4.  T-type alpha 1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts.

Authors:  P Bijlenga; J H Liu; E Espinos; C A Haenggeli; J Fischer-Lougheed; C R Bader; L Bernheim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

5.  Autocrine activation of nicotinic acetylcholine receptors contributes to Ca2+ spikes in mouse myotubes during myogenesis.

Authors:  Elena Bandi; Annalisa Bernareggi; Micaela Grandolfo; Chiara Mozzetta; Gabriella Augusti-Tocco; Fabio Ruzzier; Paola Lorenzon
Journal:  J Physiol       Date:  2005-07-21       Impact factor: 5.182

6.  Activation of nicotinic acetylcholine receptors increases the rate of fusion of cultured human myoblasts.

Authors:  R M Krause; M Hamann; C R Bader; J H Liu; A Baroffio; L Bernheim
Journal:  J Physiol       Date:  1995-12-15       Impact factor: 5.182

7.  Acetylcholinesterase inhibitors attenuate angiogenesis.

Authors:  Ryohei Miyazaki; Toshihiro Ichiki; Toru Hashimoto; Jiro Ikeda; Aya Kamiharaguchi; Eriko Narabayashi; Hirohide Matsuura; Kotaro Takeda; Kenji Sunagawa
Journal:  Clin Sci (Lond)       Date:  2012-08-01       Impact factor: 6.124

8.  Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse.

Authors:  Jiefei Yang; Bertha Dominguez; Fred de Winter; Thomas W Gould; John E Eriksson; Kuo-Fen Lee
Journal:  Nat Neurosci       Date:  2011-03       Impact factor: 24.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.